Order volume available up to 4 million tests per month, 48 million annually.


The SPERA COVID-19 Ag Test

Fast. Reliable. Effective.

FDA EUA-Authorized, Xtrava Health’s SPERA™ COVID-19 Ag Test is a rapid lateral flow immunoassay detecting antigen from SARS-CoV-2 in shallow nasal samples authorized for use at the point of care. 

No training is required and users can expect sample collection to results within 15 minutes or less.


High Performing

92% sensitivity, 97% specificity


Effective Against Variants

Proven to detect all known variants including Delta and Lambda.


15 minutes results.

Long Self Life

12 month shelf life.

Efficient Packaging

10 tests per pack. 

Read More

High Capacity

Test capacity up to 4 million tests per month.

NIH Supported

Evaluated, funded and supported by the National Institutes of Health (NIH).

U.S Company

Silicon Valley based company with best-in-class manufacturing in Japan.



More accurate than most rapid tests currently on the market, the SPERA™ COVID-19 Ag Test provides 92% sensitivity and 97% specificity.


The SPERA™ COVID-19 Ag Test is top-ranked for its ease-of-use. 

The test is authorized for use in group settings such as schools, nursing homes, workplaces as well as doctor’s offices.



Multiple tests can be run in parallel without operating any complex and slow instruments.  


Accurate and accessible testing. So we can get back to life’s simple pleasures.